Leading the Way in Russian Law
 


NEWS

more news

LEGAL UPDATES

more legal updates

PUBLICATIONS

more publications

RECENT DEALS

Legal support of the fund established by inheritors of the famous Tove Jansson in monitoring online and offline infringements and protecting their copyrights to Moomin characters in Russia
more recent deals


  • Sergey Patrakeev,
    Partner

RSS  RSS Feed to Events

EVENTS

Highlights of the 19th Russian Pharmaceutical Forum in Saint-Petersburg (video)


Lidings Law Firm, a leading legal advisor to foreign businesses in Russia, acted as Premier Partner of the 19th Russian Pharmaceutical Forum. The event organized jointly with Adam Smith Institute took place on May 21-23 at the business center of Corinthia Hotel in Saint-Petersburg.

Adam Smith Pharmaceutical Forum is a major independent international event for the business community covering key aspects of the Russian pharmaceutical segment regulation. This year, more than six hundred guests representing producers, distributors and retail chains, as well as leading experts and CEOs of the largest pharmaceutical enterprises have attended the Forum to discuss topics essential for the industry.

The program included discussions of international experts and pharmaceutical companies CEOs; pharmaceutical segment regulation and development issues; topic debates on balancing innovation rewards and goods availability; expert comments on compensation and pharma preparations delivery to the market; special topic discussion dedicated to the distribution and retail sales focused on the Russian regions, as well as a number of briefings on trademarks and patent disputes, HR management, pharmaceutical production and quality standards in Russia and pharmaceutical partner projects.

Mr. Andrey Zelenin, Partner and Head of Pharmaceutical Industry Practice at Lidings, recognized as the best Lawyer in the area of Life Sciences in Russia according to the analytical legal directory Who is Who Legal acted as a moderator at the business breakfast devoted to Developing Trademark and Patent Litigation Strategy. CEOs of leading pharmaceutical companies and leading advisors on the Russian market participated in the session.

Sergey Patrakeev, Lidings’ Counsel and Co-Head of Pharmaceutical Industry Practice presented his report “Statutory regulation of biosimilars: Russian perspective”, covering such issues as difference between “bioanalogue” and “biosimilar”, classification of the generic drug, and the five principles of substitutability for the US laws.

Lidings’ lawyers actively participated in the Regulatory Review Session where representatives of legislative and executive regulating and controlling authorities discussed current regulation of the industry including analysis of recent reforms and consideration of governmental initiatives aimed at stimulating the segment development and improvement of health care quality in Russia. “We had a productive discussion and tried to provide our audience with the most up-to-date information regarding expected regulatory decisions which may directly or indirectly influence the future of the Russian pharmaceutical industry,” – says Sergey Patrakeev who presented his report during the regulatory session.

To download the Forum’s program and find out more about the speakers, please refer to the event website.


back to Events   |   print page



TOP M&A
Legal Advisor
in Russia


Recommended in
All Key Practice Areas


Recommended Firm
for Dispute Resolution
in Russia


Best Life Sciences
Practice in Russia


Best Life Sciences practice,
recommended in corporate 

and M&A, dispute resolution 
in Russia


The Most Visible
Russian Law Firm


Recommended in
Key Practice Areas

Open Partnership: 
an inside look